Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not a subscriber? Subscribe now for unlimited access to online articles.

  • MIT/The Leuko Project
  • Cell monitor

    Monitor can detect low levels of white blood cells in chemo patients.

    • by Anne Trafton
    • June 27, 2018
    • White blood cells (marked by crosses) flow through capillaries at the base of the fingernail.

    During chemotherapy, a sharp drop in white blood cells leaves patients vulnerable to dangerous infections. In the US, one in six chemo patients is hospitalized with an infection—and about 7 percent of those infections prove fatal. Infected patients also have to miss their next chemotherapy dose, which sets back their cancer treatment.  

    A team of researchers from MIT and the Technical University of Madrid, led by Research Laboratory of Electronics postdoc Carlos Castro-Gonzalez, has now developed a portable white-blood-cell monitor. The device could be used at home, without taking blood samples, to determine whether prophylactic antibiotics and drugs that promote growth of white blood cells are needed to ward off infections.

    The tabletop prototype records video of blood cells flowing through capillaries just below the skin’s surface at the base of the fingernail. These capillaries are so narrow that white blood cells must squeeze through one at a time. That makes it easier for them to be seen by a wide-field microscope that emits blue light, which penetrates about 50 to 150 micrometers below the skin and is reflected back to a video camera.

    This story is part of the July/August 2018 Issue of the MIT News magazine
    See the rest of the issue
    Subscribe

    In tests, three human assistants watched one minute of such video for each of 11 chemotherapy patients. They detected with 95 percent accuracy whether a patient’s white-cell levels were above or below the threshold of danger. The researchers have since developed a computer algorithm using AI and machine vision that can perform the same task automatically.

    They’ve also launched Leuko, a startup that’s commercializing the technology.

    Tech Obsessive?
    Become an Insider to get the story behind the story — and before anyone else.

    Subscribe today
    Next in MIT News
    Want more award-winning journalism? Subscribe to Print + All Access Digital.
    • Print + All Access Digital {! insider.prices.print_digital !}*

      {! insider.display.menuOptionsLabel !}

      The best of MIT Technology Review in print and online, plus unlimited access to our online archive, an ad-free web experience, discounts to MIT Technology Review events, and The Download delivered to your email in-box each weekday.

      See details+

      12-month subscription

      Unlimited access to all our daily online news and feature stories

      6 bi-monthly issues of print + digital magazine

      10% discount to MIT Technology Review events

      Access to entire PDF magazine archive dating back to 1899

      Ad-free website experience

      The Download: newsletter delivery each weekday to your inbox

      The MIT Technology Review App

    /3
    You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.